482 related articles for article (PubMed ID: 23916563)
1. Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
Park KH; Chong YP; Kim SH; Lee SO; Choi SH; Lee MS; Jeong JY; Woo JH; Kim YS
J Infect; 2013 Dec; 67(6):556-64. PubMed ID: 23916563
[TBL] [Abstract][Full Text] [Related]
2. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of hematogenous vertebral osteomyelitis caused by gram-negative bacteria.
Park KH; Cho OH; Jung M; Suk KS; Lee JH; Park JS; Ryu KN; Kim SH; Lee SO; Choi SH; Bae IG; Kim YS; Woo JH; Lee MS
J Infect; 2014 Jul; 69(1):42-50. PubMed ID: 24561018
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis.
Gelfand MS; Cleveland KO
South Med J; 2004 Jun; 97(6):593-7. PubMed ID: 15255429
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
6. Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.
Aspinall SL; Friedland DM; Yu VL; Rihs JD; Muder RR
Ann Pharmacother; 1995; 29(7-8):694-7. PubMed ID: 8520082
[TBL] [Abstract][Full Text] [Related]
7. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ
Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539
[TBL] [Abstract][Full Text] [Related]
8. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
[TBL] [Abstract][Full Text] [Related]
9. The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection.
McNeil JC; Kaplan SL; Vallejo JG
Pediatr Infect Dis J; 2017 Jun; 36(6):572-577. PubMed ID: 28027279
[TBL] [Abstract][Full Text] [Related]
10. Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes.
Priest DH; Peacock JE
South Med J; 2005 Sep; 98(9):854-62. PubMed ID: 16217976
[TBL] [Abstract][Full Text] [Related]
11. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal endogenous endophthalmitis in association with pyogenic vertebral osteomyelitis.
Steeples LR; Jones NP
Eye (Lond); 2016 Jan; 30(1):152-5. PubMed ID: 26449198
[TBL] [Abstract][Full Text] [Related]
13. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
14. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
15. Independent analysis of a clinical predictive algorithm to identify methicillin-resistant Staphylococcus aureus osteomyelitis in children.
Wade Shrader M; Nowlin M; Segal LS
J Pediatr Orthop; 2013; 33(7):759-62. PubMed ID: 23872806
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA.
Livorsi DJ; Daver NG; Atmar RL; Shelburne SA; White AC; Musher DM
J Infect; 2008 Aug; 57(2):128-31. PubMed ID: 18562009
[TBL] [Abstract][Full Text] [Related]
17. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
Kullar R; Davis SL; Levine DP; Rybak MJ
Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309
[TBL] [Abstract][Full Text] [Related]
18. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]